BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10030437)

  • 1. Topiramate: uses in people with an intellectual disability who have epilepsy.
    Kerr MP
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():74-9. PubMed ID: 10030437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate for drug-resistant epilepsies.
    Yeung S; Ferrie CD; Murdoch-Eaton DG; Livingston JH
    Eur J Paediatr Neurol; 2000; 4(1):31-3. PubMed ID: 10701102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate: a new antiepileptic drug.
    Privitera MD
    Ann Pharmacother; 1997 Oct; 31(10):1164-73. PubMed ID: 9337443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate in long-term treatment of epilepsy in the intellectually disabled.
    Arvio M; Sillanpää M
    J Intellect Disabil Res; 2005 Mar; 49(Pt 3):183-9. PubMed ID: 15713193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N; Besag F; Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability.
    Mikati MA; Choueri R; Khurana DS; Riviello J; Helmers S; Holmes G
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():57-62. PubMed ID: 10030434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate: new indication. Single-agent therapy in refractory epilepsy: for a few patients only.
    Prescrire Int; 2004 Oct; 13(73):165-7. PubMed ID: 15499695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate.
    Glauser TA
    Epilepsia; 1999; 40 Suppl 5():S71-80. PubMed ID: 10530697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of pregabalin in patients with difficult-to-treat epilepsy and intellectual disability.
    Huber B; Bocchicchio M; Feuerbaum E; May T; Meinert T; Robertson E; Schorlemmer H; Wagner W; Wilking E; Seidel M
    Epilepsy Behav; 2008 Aug; 13(2):397-401. PubMed ID: 18554985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate slow dose titration: improved efficacy and tolerability.
    Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA
    Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate for intractable childhood epilepsy.
    Moreland EC; Griesemer DA; Holden KR
    Seizure; 1999 Feb; 8(1):38-40. PubMed ID: 10091847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate in the catastrophic epilepsies of childhood.
    Glauser TA
    J Child Neurol; 2000; 15 Suppl 1():S14-21. PubMed ID: 11218052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of topiramate in localization-related epilepsy in children.
    Holland KD; Wyllie PE
    J Child Neurol; 2000; 15 Suppl 1():S3-6. PubMed ID: 11218055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of topiramate in childhood and adolescent epilepsy: a clinical experience.
    Mohamed K; Appleton R; Rosenbloom L
    Seizure; 2000 Mar; 9(2):137-41. PubMed ID: 10845739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy.
    Langtry HD; Gillis JC; Davis R
    Drugs; 1997 Nov; 54(5):752-73. PubMed ID: 9360061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of topiramate.
    Bruni J
    Can J Neurol Sci; 1998 Aug; 25(3):S6-7. PubMed ID: 9706733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy.
    Kälviäinen R
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():63-7. PubMed ID: 10030435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate in patients with epilepsy and intellectual disability.
    Martin P; Schreiner A; Rettig K; Schäuble B
    Epilepsy Behav; 2009 Mar; 14(3):496-502. PubMed ID: 19162230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of topiramate in adults with intractable epilepsy, mental retardation, and developmental disabilities.
    Singh BK; White-Scott S
    Seizure; 2002 Jan; 11(1):47-50. PubMed ID: 11888260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.